Загрузка...
Sequential Oral Hydroxyurea and Intravenous Cytosine Arabinoside in Refractory Childhood Acute Leukemia: A Pediatric Oncology Group Phase I Study
At concentrations >0.1 mM, Hydroxyurea (HU) enhances the accumulation of cytosine arabinoside (ara-C) in leukemia cells in vitro. This study of children with refractory acute leukemia was designed to take advantage of this biochemical modulation. A fixed dose of HU and an escalating dose of ara-C...
Сохранить в:
Опубликовано в: : | J Pediatr Hematol Oncol |
---|---|
Главные авторы: | , , , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
2008
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601800/ https://ncbi.nlm.nih.gov/pubmed/18458568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPH.0b013e318166247e |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|